Servier and MiNA Therapeutics ink neurology pact by Lucy Parsons | Jan 22, 2021 | News | 0 Companies will develop saRNA therapies to treat neurological diseases Read More
CEPI, Imperial College partner for emerging diseases vaccines by Selina McKee | Dec 10, 2018 | News | 0 The Coalition for Epidemic Preparedness Innovations (CEPI) and Imperial College London have announced a partnership to develop a self-amplifying RNA vaccine platform (saRNA), enabling tailored vaccine production against multiple viral pathogens. Read More